Sponsor or institution
Clinical trials and research at Amicus Therapeutics
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Amicus Therapeutics that are recruiting, at sites in 15 countries (most in United States (5), Germany (3), United Kingdom (3)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 15Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term outcomes for adults with Fabry disease on migalastat | — | Birmingham, Alabama and 7 other locations | Recruiting | Apr 2, 2025 |
| Migalastat for children aged 2 to <12 with Fabry disease and amenable GLA variants | Phase 3 | Atlanta, Georgia and 11 other locations | Recruiting | Apr 1, 2025 |
| Global registry for patients with Pompe disease | — | Little Rock, Arkansas and 40 other locations | Recruiting | Nov 7, 2023 |
| Evaluating a new treatment for infantile onset glycogen storage disease | Phase 3 | Gainesville, Florida and 13 other locations | Recruiting | Mar 22, 2021 |
| Observational study of women with Fabry disease during pregnancy and breastfeeding | — | Philadelphia, Pennsylvania | Recruiting | Feb 5, 2020 |
All recruiting trials (5)
-
Long-term outcomes for adults with Fabry disease on migalastat
This project will see if migalastat (compared with enzyme replacement therapy or no treatment) helps adults with Fabry disease maintain kidney function, stay safe, and improve quality of life over several years.
-
Migalastat for children aged 2 to <12 with Fabry disease and amenable GLA variants
This test gives the oral drug migalastat to children aged 2 to <12 who have Fabry disease with GLA variants that respond to the drug to see if it is safe and how it acts in their bodies.
-
Global registry for patients with Pompe disease
This study is collecting information from people with Pompe disease to see how well current treatments work and how they affect daily life, including both those who are being treated and those who aren't.
-
Evaluating a new treatment for infantile onset glycogen storage disease
This study is testing a new treatment for infants and young children with infantile onset Pompe disease to see if it is safe and effective.
-
Observational study of women with Fabry disease during pregnancy and breastfeeding
This study looks at how pregnancy and breastfeeding affect women with Fabry disease and their babies, comparing those who have taken a treatment called migalastat to those who haven't.
Quick answers
How many clinical trials run by Amicus Therapeutics are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in United States (5 trials), Germany (3 trials), United Kingdom (3 trials), Belgium (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.